Global  

Coronavirus vaccine safe in early trial; hydroxychloroquine may increase death risk

Reuters Friday, 22 May 2020 ()
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
0
shares
ShareTweetSavePostSend
 
Video credit: Wochit - Published
News video: Coronavirus Vaccine From China Is Safe In Early Trial

Coronavirus Vaccine From China Is Safe In Early Trial 00:40

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse effects, though side effects such as fever were noted. Blood samples from the 108 vaccinated...

You Might Like


Related videos from verified sources

COVID-19 Keyword Blocking Is Down 88%: IAS’ Utzschneider [Video]

COVID-19 Keyword Blocking Is Down 88%: IAS’ Utzschneider

Education, technology and facts may now be winning back some advertisers who fled news at the start of the COVID-19 pandemic. In this video discussion with John Montgomery, GroupM's EVP of brand..

Credit: BeetTV - Affiliate     Duration: 15:48Published
Risk of COVID-19 Transmission Inside vs. Outside: Explained [Video]

Risk of COVID-19 Transmission Inside vs. Outside: Explained

Risk of COVID-19 Transmission Inside vs. Outside: Explained With stay-at-home orders loosening across the country, it’s important to remember COVID-19 transmission can and will still happen. Here are..

Credit: Wibbitz Studio     Duration: 01:35Published

Related news from verified sources

Covid 19 coronavirus: Vaccine in first human trial shows signs of creating immunity

Covid 19 coronavirus: Vaccine in first human trial shows signs of creating immunity
The first coronavirus vaccine tested on humans appears safe and generated antibodies which stopped the virus replicating, according to early trial results shared...
New Zealand Herald

Moderna’s COVID-19 vaccine trial shows promising early results, it says

The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the virus, its manufacturer, Moderna,...
ChicagoTribune


Tweets about this